Skip to main content
. 2012 May 9;15(1):139–148. doi: 10.1093/ntr/nts101

Table 2.

Smoking Outcome Measures

Abstinence measure Placebo (N = 22) Varenicline (N = 25) t Significance (p)
Days of continuous abstinence, M (SD) 9.1 (9.7) 16.4 (11.3) −2.36 .02
Participants continuously abstinent, n (%) 3 (13.6) 10 (40.0) a .05
Number of negative samples, M (SD) 2.1 (2.5) 4.1 (3.0) −2.43 .02
Hours abstinent after lapse exposure, M (SD) 148 (229) 336 (290) −2.44 .02

Note. aFisher’s exact test